These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26068418)

  • 41. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis.
    Hsu CC; Liao WY; Chan TS; Chen WY; Lee CT; Shan YS; Huang PJ; Hou YC; Li CR; Tsai KK
    J Pathol; 2019 Dec; 249(4):498-508. PubMed ID: 31465125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
    Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
    Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.
    Kim J; Hoffman JP; Alpaugh RK; Rhim AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS
    Cell Rep; 2013 Jun; 3(6):2088-99. PubMed ID: 23791528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.
    Qazi AM; Gruzdyn O; Semaan A; Seward S; Chamala S; Dhulipala V; Sethi S; Ali-Fehmi R; Philip PA; Bouwman DL; Weaver DW; Gruber SA; Batchu RB
    Surgery; 2012 Oct; 152(4):704-11; discussion 711-3. PubMed ID: 22943841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function.
    Begum A; McMillan RH; Chang YT; Penchev VR; Rajeshkumar NV; Maitra A; Goggins MG; Eshelman JR; Wolfgang CL; Rasheed ZA; Matsui W
    Pancreas; 2019 Mar; 48(3):329-334. PubMed ID: 30747824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
    Xiao Q; Zhou D; Rucki AA; Williams J; Zhou J; Mo G; Murphy A; Fujiwara K; Kleponis J; Salman B; Wolfgang CL; Anders RA; Zheng S; Jaffee EM; Zheng L
    Cancer Res; 2016 Sep; 76(18):5395-404. PubMed ID: 27496707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
    Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
    Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.
    Li X; Kang Y; Roife D; Lee Y; Pratt M; Perez MR; Dai B; Koay EJ; Fleming JB
    Oncogene; 2017 Sep; 36(38):5432-5438. PubMed ID: 28534517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nestin and other putative cancer stem cell markers in pancreatic cancer.
    Matsuda Y; Kure S; Ishiwata T
    Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
    Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
    [No Abstract]   [Full Text] [Related]  

  • 55. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
    Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
    Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
    Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
    Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.
    Tomihara H; Yamada D; Eguchi H; Iwagami Y; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Mori M; Doki Y
    Cancer Sci; 2017 Mar; 108(3):398-407. PubMed ID: 28064436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.